916 related articles for article (PubMed ID: 19670991)
1. How should we support pharmaceutical innovation?
Grootendorst P
Expert Rev Pharmacoecon Outcomes Res; 2009 Aug; 9(4):313-20. PubMed ID: 19670991
[TBL] [Abstract][Full Text] [Related]
2. Overcoming the obstacles in the pharma/biotech industry: 2008 update.
Graul AI; Revel L; Rosa E; Cruces E
Drug News Perspect; 2009; 22(1):39-51. PubMed ID: 19209298
[TBL] [Abstract][Full Text] [Related]
3. Overcoming the challenges in the pharma/biotech industry.
Graul AI; Prous JR
Drug News Perspect; 2007; 20(1):57-68. PubMed ID: 17332900
[TBL] [Abstract][Full Text] [Related]
4. [Dismantling of "Big Pharma" gives new impetus to the pharmaceutical sector. Dynamic life science clusters can increase Swedish competitiveness].
Hedner T; Gatenbeck L
Lakartidningen; 2012 Jun 27-Jul 17; 109(26-28):1280-1. PubMed ID: 22852257
[No Abstract] [Full Text] [Related]
5. China spurs pharma innovation.
Hughes B
Nat Rev Drug Discov; 2010 Aug; 9(8):581-2. PubMed ID: 20671751
[No Abstract] [Full Text] [Related]
6. Value networks identify innovation in 21st century pharmaceutical research.
Edwards PJ
Drug Discov Today; 2009 Jan; 14(1-2):68-77. PubMed ID: 18973823
[TBL] [Abstract][Full Text] [Related]
7. Can open-source drug R&D repower pharmaceutical innovation?
Munos B
Clin Pharmacol Ther; 2010 May; 87(5):534-6. PubMed ID: 20407458
[TBL] [Abstract][Full Text] [Related]
8. How to revive breakthrough innovation in the pharmaceutical industry.
Munos BH; Chin WW
Sci Transl Med; 2011 Jun; 3(89):89cm16. PubMed ID: 21715677
[TBL] [Abstract][Full Text] [Related]
9. A new prize system for drug innovation.
Gandjour A; Chernyak N
Health Policy; 2011 Oct; 102(2-3):170-7. PubMed ID: 21724290
[TBL] [Abstract][Full Text] [Related]
10. Open innovation: share or die..
Talaga P
Drug Discov Today; 2009 Nov; 14(21-22):1003-5. PubMed ID: 19778629
[No Abstract] [Full Text] [Related]
11. Drug discovery: new models for industry-academic partnerships.
Tralau-Stewart CJ; Wyatt CA; Kleyn DE; Ayad A
Drug Discov Today; 2009 Jan; 14(1-2):95-101. PubMed ID: 18992364
[TBL] [Abstract][Full Text] [Related]
12. Financial Times Global Pharmaceutical & Biotechnology Conference 2009.
Scattereggia J
IDrugs; 2010 Jan; 13(1):26-9. PubMed ID: 20024844
[TBL] [Abstract][Full Text] [Related]
13. Pharmaceutical R&D: the road to positive returns.
David E; Tramontin T; Zemmel R
Nat Rev Drug Discov; 2009 Aug; 8(8):609-10. PubMed ID: 19644471
[No Abstract] [Full Text] [Related]
14. The state of innovation in drug development.
Kola I
Clin Pharmacol Ther; 2008 Feb; 83(2):227-30. PubMed ID: 18202690
[TBL] [Abstract][Full Text] [Related]
15. Ask the experts: future of the pharmaceutical industry. Interview by Future Medicinal Chemistry.
Cottens S; Eaton M; Fuhr J; Geary S; Johnson DS; Li G; Raveglia L; Robertson GM; Westwell A
Future Med Chem; 2011 Nov; 3(15):1863-72. PubMed ID: 22023030
[TBL] [Abstract][Full Text] [Related]
16. The road ahead for large pharma: long-term science and innovation.
Lundberg JM; Reilly C
Drug Discov Today; 2009 May; 14(9-10):439-41. PubMed ID: 19429501
[No Abstract] [Full Text] [Related]
17. Mergers and innovation in the pharmaceutical industry.
Comanor WS; Scherer FM
J Health Econ; 2013 Jan; 32(1):106-13. PubMed ID: 23220457
[TBL] [Abstract][Full Text] [Related]
18. Discontinued drugs in 2010: oncology drugs.
Williams R
Expert Opin Investig Drugs; 2011 Nov; 20(11):1479-96. PubMed ID: 21955127
[TBL] [Abstract][Full Text] [Related]
19. Overcoming further challenges in the pharma/biotech industry: 2007 update.
Graul AI; Cruces E; Revel L; Serradell N; Rosa E
Drug News Perspect; 2008; 21(1):44-58. PubMed ID: 18301809
[TBL] [Abstract][Full Text] [Related]
20. The biotechnology innovation machine: a source of intelligent biopharmaceuticals for the pharma industry--mapping biotechnology's success.
Evens RP; Kaitin KI
Clin Pharmacol Ther; 2014 May; 95(5):528-32. PubMed ID: 24448474
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]